India  
 
NewsR.in

JN.1 Covid variant: Health officials asked to ensure availability of ventilators, oxygen cylinders

IndiaTimes Sunday, 24 December 2023
Maharashtra Minister Sanjay Bansode instructed health officials to ensure the availability of necessary equipment for the JN.1 Covid variant at government hospitals. In a meeting in Latur, Bansode emphasized the need for precautionary measures and availability of ventilators, oxygen cylinders, and medicines. Collector Varsha Thakur-Ghuge, CEO Anmol Sagar, SP Somay Munde, and other officials attended. The JN.1 variant has 22 reported cases in India. Testing kits are provided for symptomatic patients, and Vilasrao Deshmukh Medical College has reserved 50 beds for new cases.
0
shares		ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Covid Outrage: Doctor's Call on the Rapidly Growing JN.1 Variant in India | Oneindia News

Covid Outrage: Doctor's Call on the Rapidly Growing JN.1 Variant in India | Oneindia News 01:48

 Delhi: On Covid-19 new variant Jn.1, former AIIMS Director and Senior Pulmonologist Dr Randeep Guleria says, "...We need a vaccine which covers a broader type of the virus. We have had multiple mutations. Jn.1 is a sub lineage of Omicron. So a vaccine which is made against Omicron will be effective...

You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

AstraZeneca requests European authorisation of Covid vaccine be pulled [Video]

AstraZeneca requests European authorisation of Covid vaccine be pulled

AstraZeneca was the first pharmaceutical laboratory to launch a vaccine on the market at the end of 2020, a year after the appearance of the virus.

Credit: euronews (in English)    Duration: 00:35Published

AstraZeneca starts worldwide withdrawal of COVID vaccine

 AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy.
Sky News
AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court [Video]

AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court

AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering it unusable. This decision marks a significant development in the global vaccination effort against Covid-19. #COVID19 #Astrazeneca #COVIDVaccine #Covishield #Worldnews #Indianews #UKCourt #Oneindia #Oneindianews ~PR.320~ED.102~

Credit: Oneindia    Duration: 05:11Published

Apple reports biggest drop in iPhone sales since early months of pandemic - and reveals AI plans

 Tech giant Apple has recorded the biggest drop in iPhone sales since the early months of the COVID pandemic.
Sky News

Related videos from verified sources

Covid-19 Surge in India:Exploring JN.1 Sub-variant with Former AIIMS Director Dr MC Misra| Oneindia [Video]

Covid-19 Surge in India:Exploring JN.1 Sub-variant with Former AIIMS Director Dr MC Misra| Oneindia

India is witnessing a surge in Covid-19 cases, particularly in Kerala, where the active cases have reached 4,054. The advent of the new sub-variant, JN.1, has spurred states to heighten precautionary..

Credit: Oneindia     Duration: 17:52Published
Covid-19 sub-variant JN.1: Why are all Covid variants detected in December? | Know all | Oneindia [Video]

Covid-19 sub-variant JN.1: Why are all Covid variants detected in December? | Know all | Oneindia

Covid-19 saw three big mutations in December of 2020: Alpha (B.1.1.7), Beta (B.1.351), and Gamma (P.1). A year later, in December 2021 the Omicron variant sent the world back into their homes just..

Credit: Oneindia     Duration: 03:03Published
JN.1 Covid-19 ‘variant of interest’: India detects 21 cases across three states | Oneindia News [Video]

JN.1 Covid-19 ‘variant of interest’: India detects 21 cases across three states | Oneindia News

As the nation sees another surge in Covid cases, a new sub-variant of the virus, identified as JN.1, is making headlines with 21 reported cases across different states. The sub-variant, a descendant of..

Credit: Oneindia     Duration: 03:55Published